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Detection of Vulnerable Coronary Artery Plaques
Lesion Level Risk Assessment Within the Coronary Arterial Tree?*
John J. Young, MD, FACC
Columbus, OhioProgressive atherosclerotic disease and its clinical
sequelae remain the number one cause of mortality
in the U.S. The majority of patients with acute
coronary syndromes (ACS) present with unstable
angina, acute myocardial infarction, or sudden car-
diac death secondary to sudden luminal thrombosis.
Until recently, the prevailing clinical perception of
atherosclerosis was that of advancing luminal ste-
nosis with less attention paid to the condition of the
vessel wall. Although the demonstration of luminal
obstruction or consequent reduction in blood flow
may explain symptoms of coronary disease and
abnormalities on perfusion imaging, it does not
accurately reveal the patient’s future likelihood of
experiencing an acute coronary event. Angiographic
See page 638
and intravascular ultrasound (IVUS) studies of cor-
onary arteries before and after ACS have found that
hemodynamically insignificant lesions typically
cause these events (1–5). This has led to the
misperception that thromboses occur at sites of
minimal atherosclerotic disease, primarily based on
the lack of angiographic luminal obstruction.
Pathological studies and more recent IVUS and
optical coherence tomography data demonstrate
significant plaque accumulation at these lesion sites
vulnerable to rupture that can be masked by expan-
sive vessel remodeling (6–10).
Within any given patient, different types of
potential vulnerable plaques (VPs) with various
underlying histopathology and biology exist. Coro-
nary luminal thrombosis occurs from 3 different
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.From the Ohio State University Medical Center, Columbus, Ohio.pathologies (plaque rupture, plaque erosion, and
calcified nodules), with plaque rupture being the
most common (11). The pre-thrombosed lesion
that most resembles acute plaque rupture is the thin
cap fibroatheroma (TCFA), characterized by a ne-
crotic core with a thin (65 m) fibrous cap,
containing rare smooth muscle cells but numerous
macrophages. Autopsy studies have demonstrated a
strong correlation between plaque morphology and
ACS pathology, with TCFAs typically present at
sites 50% diameter stenosis. Identification with
subsequent therapeutic targeting of these TCFAs in
living patients may help reduce the incidence of
ACS and sudden cardiac death. To evaluate plaque
vulnerability, lesion level assessment with a variety
of techniques (noninvasive and invasive imaging
modalities) is being rigorously pursued. One such
technique is near-infrared spectroscopy (NIRS).
Near-infrared spectroscopy, a technique rou-
tinely used in the physical sciences to determine
chemical composition of substances, is under active
investigation as a potential tool to identify VP
(12–14). The impetus for this work is the high
likelihood that plaques with a distinct chemical
composition (i.e., inflamed TCFAs) represent VPs
that may be prone to rupture and result in ACS.
The goal of intracoronary NIR spectroscopy is to
provide a “chemogram” of the coronary artery wall
to serve as an index of vulnerability. In this issue of
iJACC (JACC: Cardiovascular Imaging), Gardner et
al. (15) assessed the diagnostic accuracy of NIRS
compared with that of histology in coronary artery
autopsy specimens.
Scanning NIRS was performed on 212 coronary
artery segments from 84 autopsy hearts, with the
goal of demonstrating the ability of the NIRS
system to detect lipid core plaques compared with
that of the gold standard of histology. A unique
custom fixture was used to mount the coronary
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650egments (allowing fluid flow and catheter entry)
hen examined with the NIRS in a pullback manner
imilar to IVUS. The first set of coronary segments
n  86) during the calibration phase was used to
onstruct an algorithm for the subsequent, prospec-
ive study (n  126) during the validation phase.
istopathology was performed at 2-mm intervals
ccording to a modified American Heart Associa-
ion classification scheme. The authors defined a
lipid core plaque of interest” (LCP) as a fibroathe-
oma with a lipid core 60° in circumferential
xtent, 200-m thick, with a fibrous cap 450
 m. In addition, a “lipid core burden index”
LCBI) was calculated based on the amount of lipid
ore in the entire scanned artery on a 0 to 1,000
cale. The analysis was double-blinded: those con-
tructing the algorithm in the calibration phase did
ot have access to histologic data from the valida-
ion phase, and those performing NIRS and histo-
ogic analyses during the validation phase did not
ave access to the algorithm.
The results of the NIRS algorithm for each
ullback generated a color map indicating the lipid
ontent of the arterial wall viewed from the luminal
urface termed a chemogram. The LCBI was based
n the fraction of chemogram pixel intensity, while
he block chemogram represents a summary of the
resence of LCP at 2-mm intervals in 4 probability
ategories. The pre-specified end point of the study
as the ability of NIRS to detect localized LCP in
-mm blocks of the coronary artery segment eval-
ated using receiver-operator characteristic analysis
f the NIR chemogram versus the LCP histology
alues. The LCPs were present in 4.3% blocks from
he validation hearts with the algorithm prospec-
ively identifying LCP with a receiver-operator
haracteristic area of 0.80 (95% confidence interval:
.76 to 0.85). The LCBI detected the presence or
bsence of any fibroatheroma with an area under
he curve of 0.86 (95% confidence interval: 0.81 to
.91). Both of these values are consistent with the
ccuracy of current diagnostic modalities. Retro-
pective, exploratory analysis conducted in extreme
rtery segments with either no or extensive fibro-
theroma yielded even higher area under the curve
alidation. While this latter type of exploratory
nalysis represents an artificial situation, it does
upport the ability of NIRS to discriminate tissue
ypes based on chemical composition. The main
imitation of the study as outlined by the authors is
he ex vivo nature without the dynamic motion and
ortuous anatomy of the coronary vasculature. The outhors conclude that NIRS accurately identifies
CP in coronary autopsy specimens and that this
apability will assist in the management of patients
ith coronary artery disease (CAD).
This study builds on previous evidence that
IRS can identify plaque composition and features
ssociated with plaque vulnerability in post-mortem
uman specimens (12,13). The authors should be
ommended for conducting a rigorous calibration
nd validation study of this novel intravascular
maging device for VP that has not been uniformly
dopted by other current clinically available tech-
iques. This autopsy validation, together with early
linical results, provides a new tool to identify lipid
ore plaques in patients with atherosclerosis. The
uthors discuss the potential use of NIRS for
mproved risk stratification in patients at higher risk
f subsequent coronary events, as well as potentially
uiding therapy—whether it be medical, catheter-
ased (stent), or even surgical. The combination of
IRS (biology) with current IVUS or optical co-
erence tomography imaging devices (anatomic)
ould certainly improve diagnostic information at
he time of intravascular assessment. The ultimate
oal, however, in assessing VP is to prevent ACS in
atients at highest risk. Although noninvasive im-
ging holds future promise for risk stratification, the
ompelling near-term opportunity rests with CAD
atients who present daily to the catheterization
aboratory (16). Lesion-level risk stratification with
hese invasive VP imaging devices should be seen as
omplementary to current diagnostic techniques.
tilizing traditional and evolving markers of risk
ives a more complete picture in assessing the
atient’s prognosis by defining the stage of athero-
clerotic disease and aligning the appropriate treat-
ent. Ongoing natural history studies and registries
re needed to determine the preventative effective-
ess of these diagnostic techniques as well as
roposed interventional VP therapies. In conclu-
ion, further studies are warranted to determine if
etection of LCP by NIRS imaging will contribute
o enhanced prediction of outcomes in patients with
nown CAD.
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00, Columbus, Ohio 43210. E-mail: john.young2@
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